Get all your news in one place.
100's of premium titles.
One app.
Start reading
Fortune
Fortune
Sheryl Estrada

Moderna’s CFO on the $25 billion innovation plan to work past the post-COVID slump

Facade with logo and snow at headquarters of pharmaceutical company Moderna in Cambridge, Massachusetts

Good morning.

Moderna is repositioning itself in the biotechnology space by betting on new innovation based on its mRNA platform. Moderna CFO Jamey Mock will play a major role in mitigating risk in these big investments as demand for the company’s only marketable product at this time—the COVID-19 vaccine—lags. 

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.